Literature DB >> 16678604

Extended donor criteria in lung transplantation: impact on organ allocation.

Phil Botha1, Dipesh Trivedi, Christopher J Weir, Cait P Searl, Paul A Corris, John H Dark, Stephan V B Schueler.   

Abstract

OBJECTIVE: Some reports have documented a higher early mortality with the use of extended criteria donors in lung transplantation. None have evaluated how outcomes compare with the use of these organs for single and bilateral transplantation or whether this practice results in a higher incidence of early bronchiolitis obliterans syndrome.
METHODS: We performed a retrospective review of case notes, intensive therapy unit database, and donor details. Between January 1, 2000, and December 31, 2004, 201 patients underwent lung or heart-lung transplantation.
RESULTS: Eighty-three (41.3%) patients received organs deemed marginal on the basis of at least one of the following criteria: donor age greater than 55 years, duration of ventilation greater than 5 days, purulent secretions or inflammation at bronchoscopy, smoking of 20 or more cigarettes per day, abnormality on chest roentgenogram, or PO2/fraction of inspired oxygen ratio of less than 300 mm Hg immediately before donor organ procurement. Recipients of marginal lungs had a higher incidence of severe (grade 3) primary graft dysfunction (43.9% vs 27.4%, P = .015) and 90-day organ-specific mortality (15.7% vs 5.1%, P = .012). Bilateral transplantation carried a significantly higher 30-day mortality if performed with marginal organs (17.0% vs 2.7% with standard donor organs, P = .005). Thirty-day mortality was not significantly different for the transplantation of single marginal or standard donor lungs. Cumulative survival and survival free of bronchiolitis obliterans syndrome was not affected by marginal donor status.
CONCLUSION: Transplantation of extended criteria donor lungs leads to a higher incidence of primary graft dysfunction. Bilateral transplantation with these organs seems to confer less reserve, resulting in a higher early mortality rate. Medium-term functional outcome is, however, not adversely affected by the relaxation of donor criteria.

Entities:  

Mesh:

Year:  2006        PMID: 16678604     DOI: 10.1016/j.jtcvs.2005.12.037

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  24 in total

Review 1.  Selecting lung transplant candidates: where do current guidelines fall short?

Authors:  Jaime L Hook; David J Lederer
Journal:  Expert Rev Respir Med       Date:  2012-02       Impact factor: 3.772

2.  The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease.

Authors:  Jeffrey C Munson; Jason D Christie; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2011-08-25       Impact factor: 21.405

Review 3.  Does the use of extended criteria donors influence early and long-term results of lung transplantation?

Authors:  Marco Schiavon; Pierre-Emmanuel Falcoz; Nicola Santelmo; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-25

4.  Interim report of the Japanese original donor evaluation and management system: the medical consultant system.

Authors:  Tomoyuki Nakagiri; Masayoshi Inoue; Masato Minami; Yasushi Hoshikawa; Masayuki Chida; Toru Bando; Takahiro Oto; Takeshi Shiraishi; Naoya Yamasaki; Juntaro Ashikari; Yoshiki Sawa; Meinoshin Okumura
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

Review 5.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

Review 6.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

7.  Cell replacement in human lung bioengineering.

Authors:  Brandon A Guenthart; John D O'Neill; Jinho Kim; Kenmond Fung; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Heart Lung Transplant       Date:  2018-11-22       Impact factor: 10.247

8.  Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation.

Authors:  Shengnan Li; Shu Wang; Raghavan Murugan; Ali Al-Khafaji; Daniel J Lebovitz; Michael Souter; Susan R N Stuart; John A Kellum
Journal:  J Crit Care       Date:  2018-08-18       Impact factor: 3.425

9.  Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.

Authors:  Cynthia E Wagner; Nicolas H Pope; Eric J Charles; Mary E Huerter; Ashish K Sharma; Morgan D Salmon; Benjamin T Carter; Mark H Stoler; Christine L Lau; Victor E Laubach; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-30       Impact factor: 5.209

10.  Clinical risk factors for primary graft dysfunction after lung transplantation.

Authors:  Joshua M Diamond; James C Lee; Steven M Kawut; Rupal J Shah; A Russell Localio; Scarlett L Bellamy; David J Lederer; Edward Cantu; Benjamin A Kohl; Vibha N Lama; Sangeeta M Bhorade; Maria Crespo; Ejigayehu Demissie; Joshua Sonett; Keith Wille; Jonathan Orens; Ashish S Shah; Ann Weinacker; Selim Arcasoy; Pali D Shah; David S Wilkes; Lorraine B Ware; Scott M Palmer; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2013-01-10       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.